Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
Breast Cancer Research : BCR|June 5, 2015
High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epitheliumCecilia W Huo, Grace Chew, Prue Hill, et al.Oncogene|June 9, 2004
Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancersJane E Armes, Fleur Hammet, Melanie de Silva, et al.Annals of Surgical Oncology|November 20, 2015
Australian Multicenter Study of Isolated Limb Infusion for MelanomaHidde M Kroon, Brendon J Coventry, Mitchell H Giles, et al.The Journal of Investigative Dermatology|December 26, 2025
Evaluation of clonality in lentigo malignaSophie Soyeon Lim, Peinan Zhao, Nicholas C Wong, et al.Cancer Research|March 3, 2017
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2+ TumorsMikolaj Medon, Eva Vidacs, Stephin J Vervoort, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized TrialJonathan G Hiller, Steven W Cole, Elizabeth M Crone, et al.The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.Annals of Surgical Oncology|September 14, 2019
Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of LifeMichael A Henderson, D Gyorki, B H Burmeister, et al.Cancer Research|June 22, 2016
CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to TumorigenicitySamantha E Boyle, Clare G Fedele, Vincent Corbin, et al.Pageof 8